[Featured Stocks] Foreign Investors Surprised by 'Anti-Short Selling Movement' Net Buy... Celltrion and HL Biotech Stock Prices Rise

Amid a short-selling backlash against game retailer GameStop in the New York stock market, the Financial Services Commission will decide this month whether to extend the ban on short selling. The photo shows an employee at a financial institution in Seoul working. Photo by Hyunmin Kim kimhyun81@

[Asia Economy Reporter Ji Yeon-jin] The stock prices of Celltrion and HL Biotech, which have large short-selling balances, are soaring on the 1st. Attention is focused on whether the GameStop incident, where stock prices skyrocketed due to a short-selling boycott movement by individual investors in the U.S. New York Stock Exchange, will be replicated domestically.

As of 9:30 a.m. on the day, Celltrion is trading at 367,000 KRW, up 13.27% compared to the previous trading day. Foreign investors bought nearly 111.9 billion KRW worth, making it the top net purchase stock by foreigners on the KOSPI this morning.

At the same time, on the KOSDAQ, LH Biotech is recording 97,800 KRW, up 8.33% from the previous session. Among the stocks heavily bought by foreign investors in the KOSDAQ market, HL Biotech ranks second after Celltrion Healthcare.

Earlier, individual investors threatened to take collective shareholder action centered on Celltrion and HL Biotech, which have large short-selling balances in Korea, in connection with the U.S. anti-short-selling issue. Celltrion's short-selling balance is 2.1463 trillion KRW, and HL Biotech's is 313.8 billion KRW, recording the largest short-selling balances in the KOSPI and KOSDAQ, respectively.

This content was produced with the assistance of AI translation services.